$ONCE News
Last published 6y ago
- 6y agoONCERoche concludes acquisition of Spark Therapeutics, Inc. to strengthen presence in gene therapyGlobeNewswireSpark will continue its operations in Philadelphia as an independent company within the Roche Group Basel, 17 December 2019 - Roche (SIX: RO, ROG; OTCQX: RHHBY) and Spark Therapeutics,...
- 6y agoONCERoche purchases shares in tender offer for Spark Therapeutics, Inc.GlobeNewswireRoche intends to complete Spark acquisition today Basel, 17 December 2019 - Roche (SIX: RO, ROG; OTCQX: RHHBY) and Spark Therapeutics, Inc. (NASDAQ: ONCE) (“Spark”) today announced that Roche’s...
- 6y agoONCERoche and Spark Therapeutics, Inc. announce unconditional clearance by UK Competition and Markets AuthorityGlobeNewswireBasel, 16 December 2019 - Roche (SIX: RO, ROG; OTCQX: RHHBY) and Spark Therapeutics, Inc. (NASDAQ: ONCE) (“Spark”) today announced that the UK Competition and Markets Authority has unconditionally...
- 6y agoONCERoche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc. to December 16, 2019GlobeNewswireBasel, 9 December 2019 - Roche (SIX: RO, ROG; OTCQX: RHHBY) and Spark Therapeutics, Inc. (NASDAQ: ONCE) (“Spark”) today announced that Roche has extended the offering period of its previously...
- 6y agoONCERoche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc.GlobeNewswireBasel, 22 November 2019 - Roche (SIX: RO, ROG; OTCQX: RHHBY) and Spark Therapeutics, Inc. (NASDAQ: ONCE) (“Spark”) today announced that Roche has extended the offering period of its previously...
- 7y agoONCERoche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc.GlobeNewswireBasel, 29 October 2019 - Roche (SIX: RO, ROG; OTCQX: RHHBY) and Spark Therapeutics, Inc. (NASDAQ: ONCE) (“Spark”) today announced that Roche has extended the offering period of its previously...
- 7y agoONCESpark Therapeutics Wins Prix Galien USA Award for LUXTURNA® (voretigene neparvovec-rzyl) as Best Biotechnology ProductGlobeNewswirePHILADELPHIA, Oct. 25, 2019 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ:ONCE), a fully integrated, commercial gene therapy company dedicated to challenging the inevitability of genetic disease,...
- 7y agoONCERoche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc.GlobeNewswireBasel, 30 September 2019 - Roche (SIX: RO, ROG; OTCQX: RHHBY) and Spark Therapeutics, Inc. (NASDAQ: ONCE) (“Spark”) today announced that Roche has extended the offering period of its previously...
- 7y agoONCERoche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc.GlobeNewswireBasel, 3 September 2019 - Roche (SIX: RO, ROG; OTCQX: RHHBY) and Spark Therapeutics, Inc. (NASDAQ: ONCE) (“Spark”) today announced that Roche has extended the offering period of its previously...
- 8y agoONCESpark Therapeutics, Inc. (ONCE) CEO Jeffrey Marrazzo on Q3 2018 Results - Earnings Call TranscriptEarnings Call Transcripts
- 8y agoONCESpark Therapeutics' (ONCE) CEO Jeffrey Marrazzo on Q4 2017 Results - Earnings Call TranscriptEarnings Call Transcripts
- 8y agoONCESpark Therapeutics' (ONCE) Special Call Broker Conference Call (Transcript)Earnings Call Transcripts
- 9y agoONCESpark's (ONCE) CEO Jeff Marrazzo on Q1 2017 Results - Earnings Call TranscriptEarnings Call Transcripts
- 10y agoONCESpark Therapeutics, Inc.'s (ONCE) CEO Jeffrey Marrazzo on Q2 2016 Results - Earnings Call TranscriptEarnings Call Transcripts
- 10y agoONCESpark Therapeutics' (ONCE) CEO Jeff Marrazzo on Q4 2015 Results - Earnings Call TranscriptEarnings Call Transcripts
- 10y agoGSVCLOBOLLIONCE+3Emerald Investment Conference Shadows Groundhog Day – Investment Professionals Gathering in Philadelphia on February 3rdBusiness WireLANCASTER, Pa.--(BUSINESS WIRE)--While the world’s attention turns to Pennsylvania on February 2nd for Groundhog Day prognostications about continuing winter weather, investment professionals will gather in Philadelphia on February 3rd for the 2016 Emerald Asset Management Groundhog Day Investment Forum. The Forum is the unofficial kick-off to the year ahead as Emerald’s team of analysts and portf ...
- 10y agoGSVCLOBONCETREXWHAT’S AHEAD FOR 2016: Investment Trends and Themes to be Highlighted at the Emerald Groundhog Day Investment ForumBusiness WireLANCASTER, Pa.--(BUSINESS WIRE)--Join Emerald Asset Management for the 23rd annual Groundhog Day Investment Forum on February 3rd in Philadelphia. The Forum is the unofficial kick-off to the year ahead as Emerald’s team of analysts and portfolio managers present their key investment themes and trends for 2016, focusing on these key sectors: